Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients

por Ben-Dov, Iddo Z., Tzukert, Keren, Aharon, Michal, Pri-Chen, Hadas, Oster, Yonatan, Oiknine-Djian, Esther, Wolf, Dana G., Dranitzki Elhalel, Michal
Publicado 2022

Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up

por Ben-Dov, Iddo Z., Oster, Yonatan, Tzukert, Keren, Alster, Talia, Bader, Raneem, Israeli, Ruth, Asayag, Haya, Aharon, Michal, Burstein, Ido, Pri-Chen, Hadas, Imam, Ashraf, Abel, Roy, Mor-Yosef Levi, Irit, Khalaileh, Abed, Oiknine-Djian, Esther, Bloch, Aharon, Wolf, Dana G., Dranitzki Elhalel, Michal
Publicado 2022